21647 ⎘
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups -
Subcutaneously administered anti-IL-6 receptor antibody
#302Antiproliferative compounds and methods of use thereof
#303Altering microbial populations and modifying microbiota
#304METHOD OF TREATING KRAS-ASSOCIATED CANCERS
#305FORMULATIONS AND METHODS FOR THE TREATMENT OF CANCERS
#306Substituted esters containing polyols and saccharides for treating hepatotoxicity and fatty liver diseases
#307Soft gelatin capsules containing a mixture of analgesics and decongestants, expectorants, antitussives and/or antihistamines
#308FLT3-specific chimeric antigen receptors and methods using same
#309COMPOSITIONS COMPRISING LOPINAVIR AND TREATMENT OF CONDITIONS
#310Derivatives of korormicin useful as antibiotics
#311AMORPHOUS SOLID FORM OF COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENYL-4-YL]-METHYL}-VALINE AND (2R,4S)-5-BIPHENYL-4-YL-4-(3-CARBOXY-PROPIONYLAMINO)-2-METHYL-PENTANOIC ACID ETHYL ESTER MOIETIES AND SODIUM CATIONS
#312Nanoparticles for treatment of posterior segment ocular diseases and conditions
#313Compositions and methods for treating and preventing infections
#314Herb medicine composition for alleviating or treating asthma, and oriental pharmacopuncture solution containing same and injection containing same
#315Methods and compositions for controlling or reducing pests
#316Altering microbial populations and modifying microbiota
#317ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA
#318Compositions and methods for viral sensitization
#319Inhibitors of KRAS G12C and methods of using the same
#320Medicine combinations and treatment of restless leg syndrome
#321Agent for use in the treatment of glioma
#322Polynucleotides encoding monoclonal antibodies binding to human pituitary adenylate cyclase-activating polypeptide type I receptor (PAC1) and methods of making thereof
#323Methods for treating and Pharmaceutical compositions
#324USE OF SUBSTITUTED HEXITOLS INCLUDING DIANHYDROGALACTITOL AND ANALOGS TO TREAT NEOPLASTIC DISEASE AND CANCER STEM CELLS INCLUDING GLIOBLASTOMA MULTIFORME AND MEDULLOBLASTOMA
#325Pharmaceutical compositions of pimobendan
#326CARRIER-BINDING AGENT COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
#327MicroRNA-198 as a tumor suppressor in ovarian cancer
#328Pre-filled pharmaceutical package comprising a liquid formulation of a VEGF-antagonist
#329COMBINATION THERAPY WITH AN ANTI BCMA ANTIBODY AND A GAMMA SECRETASE INHIBITOR
#330ANTI-FOLR1 IMMUNOCONJUGATES AND ANTI-PD-1 ANTIBODY COMBINATIONS
#331Extended release methazolamide formulation
#332Methods for the treatment of glioblastoma multiforme
#333More potent and less toxic formulations of epinephrine and methods of medical use
#334METHODS OF TREATING BREAST CANCER
#335COMBINED THERAPY FOR NMDAR ANTAGONIST-RESPONSIVE NEUROPSYCHIATRIC DISORDERS
#336USE OF SUBSTITUTED HEXITOLS INCLUDING DIANHYDROGALACTITOL AND ANALOGS TO TREAT NEOPLASTIC DISEASE AND CANCER STEM CELLS INCLUDING GLIOBLASTOMA MULTIFORME AND MEDULLOBLASTOMA
#337PHARMACEUTICAL USE
#338Compositions of Azadirachta Indica and Methods of Treating Cancer
#339Compositions and methods for treatment of homocystinuria
#340COMPOSITIONS FOR TREATING CANDIDIASIS INFECTIONS
#341COMPOSITIONS AND METHODS FOR TREATING CANCER
#342COMPOSITIONS AND METHODS FOR TREATING ISCHEMIC STROKE
#343Composition, Formulations and Methods of Making and Using Botanicals and Natural Compounds for the Promotion of Healthy Brain Aging
#344Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy
#345Treatment of Constipation-Predominant Irritable Bowel Syndrome
#346Multiple viral antigen COVID vaccine and therapeutic
#347PRIMED MUSCLE PROGENITOR CELLS AND USES THEREOF
#348THERAPY AND PREVENTION OF PRION PROTEIN COMPLEX INFECTIONS IN NON-HUMAN ANIMALS
#349Methods for treating cancer
#350Method of identifying a biologically-active composition from a biofilm
#351BIOORTHOGONAL COMPOSITIONS
#352COMPOSITIONS, COMBINATIONS AND RELATED METHODS FOR PHOTOIMMUNOTHERAPY
#353Compositions comprising nicotinamide riboside and a urolithin
#354PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#355PIC1 VARIANTS WITH IMPROVED SOLUBILITY AND METHODS OF USING THE SAME
#356MicroRNA Compounds and Methods for Modulating MIR-10B Activity
#357RESIQUIMOD TOPICAL AND INJECTABLE COMPOSITIONS FOR THE TREATMENT OF NEOPLASTIC SKIN CONDITIONS
#358COMBINATION PRODUCT FOR THE TREATMENT OF CANCER
#359Combination Therapy for Metastatic Cancer
#360Anti-EGFR combinations for treating tumors
#361Alpha and gamma-D polyglutamated pemetrexed antifolates and uses thereof
#362Alpha polyglutamated pemetrexed and uses thereof
#363Polyglutamated pemetrexed and uses thereof
#364Combinations and uses thereof
#365ANTISENSE OLIGOMERS FOR TREATMENT OF AUTOSOMAL DOMINANT MENTAL RETARDATION-5 AND DRAVET SYNDROME
#366COMBINATION THERAPY INCLUDING SAPC-DOPS FOR THE TREATMENT OF PANCREATIC CANCER
#367Therapeutic regimen
#368PAC-1 COMBINATION THERAPY
#369Buffered microencapsulated compositions and methods
#370Dihydroxyphenyl Neurotransmitter Compounds, Compositions And Methods
#371Agent for use in the case of fructose intolerance
#372COMPOSITIONS AND METHODS FOR CANCER EXPRESSING PDE3A OR SLFN12
#373Combination therapies for the treatment of cancer
#374Methods for radiotherapy to trigger light activation drugs
#375GENETICALLY MODIFIED NK-92 CELLS HAVING A SAFETY SWITCH
#376Dosage form for treating severe asthma
#377Curcuphenol compounds for increasing MHC-I expression
#378Compositions and methods useful for the prevention of malaria and dengue virus transmission
#379Assessment of coronary heart disease with carbon dioxide
#380Ophthalmic compositions and methods of use therefor
#381Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their use
#382Salts of cycloserine compounds and applications thereof
#383Methods suitable for the treatment of acne
#384Methods and compositions suitable for the treatment of acne
#385Compositions comprising amino acids for use in the treatment of mucositides in neoplasia patients undergoing radiation therapy and/or chemotherapy
#386Methods suitable for disrupting a biofilm, and/or killing bacteria contained in a biofilm
#387THERAPEUTIC COMBINATION COMPRISING A PULMONARY SURFACTANT AND A STEROID FOR THE TREATMENT OF EVOLVING BPD
#388COMBINATION THERAPY OF HBV AND HDV INFECTION
#389Methods of using anti-CD79b immunoconjugates
#390Solid Pharmaceutical Formulation of PARP Inhibitors and Use Thereof
#391SYNERGISTIC COMPOSITION FOR MAINTENANCE OF HEALTHY BALANCE OF MICROFLORA
#392Combination of a PD-1 antagonist and a VEGFR/FGFR/RET tyrosine kinase inhibitor for treating cancer
#393Methods and compositions comprising ursolic acid and/or resveratrol for treating obesity, diabetes, or cancer
#394METHODS AND COMPOSITIONS TO GRAFT BONE USING IRON EXCIPIENTS
#395COMPOSITIONS AND METHODS FOR TREATING MULTIPLE SCLEROSIS
#396INHIBITORS OF BRUTON'S TYROSINE KINASE
#397Combination Therapy for Male Sexual Dysfunction
#398Immunogenic antigen identification from a pathogen and correlation to clinical efficacy
#399METHODS FOR MANUFACTURING PHTHALOCYANINE DYE CONJUGATES AND STABLE CONJUGATES
#400Bispecific EGFR/c-Met antibodies
#401Compositions and methods of treating sarcoma lung metastasis
#402COMBINATION THERAPY FOR TREATING MALIGNANCIES
#403Use of rasagiline for the treatment of restless legs syndrome
#404Method for supporting memory function and/or cognitive function
#405Methods and compositions for preventing or treating tissue calcification
#406Oral care product formulation
#4074'-Fluoro-2'-Methyl Substituted Nucleoside Derivatives as Inhibitors of HCV RNA Replication
#408Composition comprising combination of rapamycin and metformin and use thereof for treating neoplastic diseases
#409COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENYL-4-YL]-METHYL}-VALINE AND (2R,4S)-5-BIPHENYL-4-YL-4-(3-CARBOXY-PROPIONYLAMINO)-2-METHYL-PENTANOIC ACID ETHYL ESTER MOIETIES AND CATIONS
#410Methods for Diagnosis of Tuberculosis
#411ANTIBIOTIC SOLUTION AND METHOD OF INJECTION TO PREVENT OPHTHALMIC INFECTIONS
#412MACROPINOCYTOSIS IN CANCER
#413TREATMENT OF HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS
#414Lipid disulfide prodrugs and uses related thereto
#415Compositions and methods for treating autism
#416Use of short chain fatty acids for the treatment and prevention of diseases and disorders
#417Adjuvant treatment of HER2-positive breast cancer
#418Cell preparation for extemporaneous use, useful for healing and rejuvenation in vivo
#419Curcuminoid composites
#420MODULATING IMMUNE RESPONSES
#421METHODS FOR TREATING SUBJECTS WITH PRADER-WILLI SYNDROME OR SMITH-MAGENIS SYNDROME
#422GLYCOPROTEINS HAVING LIPID MOBILIZING PROPERTIES AND THERAPEUTIC USES THEREOF
#423COMPOSITIONS OF AZADIRACHTA INDICA AND METHODS OF TREATING CANCER
#4244,6-PYRIMIDINYLENE DERIVATIVES AND USES THEREOF
#425Composition comprising HMSs/HMOs and use thereof
#426Ethynyl derivatives
#427Platelet lysate compositions and uses thereof
#428METHODS AND COMPOSITIONS FOR EXTENDING LIFESPAN
#429Carborane compounds and methods of use thereof
#430ExPEC glycoconjugate vaccine formulations
#431OCULAR FORMULATIONS FOR DRUG-DELIVERY AND PROTECTION OF THE ANTERIOR SEGMENT OF THE EYE
#432CANNABIS OIL COMPOSITIONS AND METHODS FOR PREPARATION THEREOF
#433Compositions and methods of enhancing anti-tumor response using hybrid neutrophils
#434COMBINATION THERAPIES
#435Dietary Supplement Comprising Beta-Glucan and Casein Hydrolysate for Improving Health and Growth Performance in a Mammal
#436Compositions and methods for inhibiting arginase activity
#437Macrocyclic compound and uses thereof
#438METHODS AND DEVICES FOR THE TREATMENT OF OCULAR DISEASES IN HUMAN SUBJECTS
#439Materials and methods for controlling infections
#440GM-CSF/CD40L VACCINE AND CHECKPOINT INHIBITOR COMBINATION THERAPY
#441COMBINED USE OF GDF TRAPS AND ERYTHROPOIETIN RECEPTOR ACTIVATORS TO INCREASE RED BLOOD CELL LEVELS
#442Method of treating Crohn's disease by administering a triple combination therapy of anti-integrin antibody, adalimumab and methotrexate
#443ALUMINUM BASED ADJUVANTS FOR TOLEROGENIC VACCINATION
#444IMMUNOTHERAPY FOR CANCER
#445Methods and Compositions for Treating Thyroid-Related Medical Conditions with Reduced Folates
#446Systems and methods for treating cancer
#447Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
#448USE OF RASAGILINE FOR THE TREATMENT OF RESTLESS LEGS SYNDROME
#449Genetically modified NK-92 cells and monoclonal antibodies for the treatment of cancer
#450Phenylalanine small organic compounds to directly modulate PCSK9 protein activity
#451Combination therapy for treatment of restenosis
#452Riluzole prodrugs and their use
#453PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE
#454Antibodies, pharmaceutical compositions and methods
#455Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
#456COMBINATION THERAPIES FOR TREATMENT OF CANCER
#457Riluzole prodrugs and their use
#458Pre-filled pharmaceutical package comprising a liquid formulation of a VEGF-antagonist
#459Methods for treating heart disease in a subject with Friedreich's ataxia by an aromatic-cationic peptide
#460Process and compositions for enhancing energy expenditure
#461Herbal nutraceutical formulation to reduce oxidative stress, viral and microbial infections, and inflammation
#462Bicarbonate as a potentiator for antimicrobial agents
#463Methods and compositions to inhibit dependence on opioids
#464Compositions and methods for invasive and non-invasive procedural skincare
#465FORMULATION OF NANOSTRUCTURED GELS FOR INCREASED AGENT LOADING AND ADHESION
#466Combination of a PD-1 antagonist and CpG-C type oligonucleotide for treating cancer
#467THERAPY OF ATHEROSCLEROSIS, PRIMARY BILIARY CIRRHOSIS AND NRLP3 INFLAMMASOME-ASSOCIATED DISEASE BY HTCP INHIBITORS
#468COMPOSITIONS OF BUPRENORPHINE AND µ ANTAGONISTS
#469COMBINATION OF RIBOCICLIB AND DABRAFENIB FOR TREATING OR PREVENTING CANCER
#470Small molecule inhibitors of the nuclear translocation of androgen receptor for the treatment of castration-resistant prostate cancer
#471APOPTOTIC CELL-MEDIATED INDUCTION OF ANTIGEN SPECIFIC REGULATORY T-CELLS FOR THE THERAPY OF AUTOIMMUNE DISEASES IN ANIMALS AND HUMANS
#472Combined preparations for the treatment of cancer or infection
#473Compounds and methods for treating influenza
#474Crystalline polymorphic forms of monosodium n-[-8-(2-hydroxybenzoyl)amino]caprylate
#475Platform drug delivery system utilizing crystal engineering and theanine dissolution
#476POLYNUCLEOTIDE AGENTS TARGETING ANGIOTENSINOGEN (AGT) AND METHODS OF USE THEREOF
#477Substituted imidazo[1,5-a]pyrimidines and their use in the treatment of medical disorders
#478COMBINATION OF BCL-2 INHIBITOR AND MEK INHIBITOR FOR THE TREATMENT OF CANCER
#479Treatment and management of augmentation in restless legs syndrome
#480Novel class of compounds for the treatment of cardiovascular disease.
#481PROCESSES FOR GENERATING ENGINEERED CELLS AND COMPOSITIONS THEREOF
#482Curcumin-based compositions and methods of use thereof
#483Traditional Chinese medicine composition for treating diseases caused by human papillomavirus, preparation method and use thereof
#484TANK-BINDING KINASE-1 PROTACs AND ASSOCIATED METHODS OF USE
#485ANTIBIOTIC GEL FORMULATION AND METHODS OF PREPARING THE ANTIBIOTIC GEL FORMULATION
#486Altering microbial populations and modifying microbiota
#487Treatment of angiogenesis disorders
#488Ferroportin inhibitors
#489Synergistic herbal compositions for testosterone boosting
#490USE OF RASAGILINE FOR THE TREATMENT OF RESTLESS LEGS SYNDROME
#491DYNAMIN 2 INHIBITOR FOR THE TREATMENT OF DUCHENNE'S MUSCULAR DYSTROPHY
#492Compositions and methods for inhibiting kinases
#493Compositions and methods for treatment of pre-cancerous skin lesions
#494Formulations for treatment of post-traumatic stress disorder
#495Compositions and methods for treating autism
#496Methods of treating spinal cord injury using a chondroitin sulfate proteoglycan (CSPG) reduction peptide (CRP) comprising a cell membrane penetrating domain, a CSPG binding domain, and a lysosome targeting domain
#497Drug releasing coatings for balloon catheters
#498Utilizing polymers and antibiotics to enhance antimicrobial activity and inhibit antibiotic resistance
#499Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
#500Particles for spatiotemporal release of agents
#501Mixtures of cannabinoid compounds, and production and use thereof
#502CD200 inhibitors and methods of use thereof
#503Interleukin 15 protein complex and use thereof
#504Formulation including a combination of beta-endorphin and adrenocorticotropic hormone
#505RAR selective agonists in combination with immune modulators for cancer immunotherapy
#506Bisphenol ether derivatives and methods for using the same
#507Benzamide and active compound compositions and methods of use
#508Trace element solution
#509CONTROLLED-RELEASE TOZADENANT FORMULATIONS
#510Compound to treat Sjogren's Syndrome
#511BACTERIAL TOXINS AND USES THEREOF AS RAS SPECIFIC PROTEASES FOR TREATING CELL PROLIFERATION DISEASES AND DISORDERS
#512Cyclic compound/peptide comprising an A-beta13-16 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-beta13-16 peptide
#513Cyclic compound/peptide comprising an A-beta15-18 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-BETA15-18 peptide
#514Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
#515Herbal compositions and methods for the prevention and treatment of nail infections
#516Biologically relevant orthogonal cytokine/receptor pairs
#517METHODS OF TREATING TRANSPLANT REJECTION
#518Compositions and methods for reducing major adverse cardiovascular events
#519Treatment of ovarian cancer in patients with ascites using a specific binding agent of human angiopoietin-2 in combination with a taxane
#520CANCER THERAPY WITH A PARVOVIRUS COMBINED WITH BEVACIZUMAB
#521Nanoparticles for treatment of posterior segment ocular diseases and conditions
#522Pharmaceutical compositions of pimobendan
#523Carbonic anhydrase enzymes for regulating mast cell hematopoiesis and type 2 inflammation
#524Compositions for use in the treatment of diabetes
#525Heterocyclic inhibitors of ATR kinase
#526METHODS AND COMPOSITIONS FOR TREATING HERPESVIRUS INDUCED CONDITIONS
#527Anti-CTLA-4 antibodies and uses thereof
#528Compositions comprising cyclic peptides derived from an A-beta peptide
#529PRINTABLE CANNABINOID AND TERPENE COMPOSITIONS
#530Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
#531Nucleic acid nanocapsules for drug delivery and targeted gene knockdown
#532Drug releasing coatings for medical devices
#533PROBIOTIC PATHOGEN INHIBITION COMPOSITION AND METHOD
#534Cell preparations for extemporaneous use, useful for healing and rejuvenation in vivo
#535METHOD FOR TREATING CANCER USING HSP90 INHIBITORS
#536Biologic composition and method of manufacture
#537Isothiocyanate functional surfactants, formulations incorporating isothiocyanate functional surfactants and associated methods for treating biofilms
#538Methods for culturing and/or differentiating hematopoietic stem cells into progenitors and uses thereof
#539Transdermal Delivery
#540USE OF RASAGILINE FOR THE TREATMENT OF RESTLESS LEGS SYNDROME
#541Methods for treating a headache condition using anti-human PAC1 antibodies or antigen-binding fragments thereof
#542Combination Of The Application Of Antibodies For Immunostimulation Together With Glucocorticoids
#543Small molecule Ras inhibitors
#544HEALING TOPICAL COMPOSITION
#545Methods and compositions relating to bispecific anti-CHI3L1 antibody reagents for the treatment of cancer
#546Tetracyclic heterocycle compounds useful as HIV integrase inhibitors
#547Hematopoietic stem cells in combinatorial therapy with immune checkpoint inhibitors against cancer
#548METHODS FOR TREATING MUSCULAR DYSTROPHY
#549Methods and compositions for the activation of gamma-delta T-cells
#550ENHANCEMENT OF IMPAIRED MOTOR AND MENTAL FUNCTIONS, USING DEXTROMETHORPHAN AND OXIDASE ENZYME INHIBITOR
#551Bromodomain and extra-terminal protein inhibitor combination therapy
#552Estrogen receptor ligand treatment for neurodegenerative diseases
#553Multiphasic compositions
#554Peptide and pharmaceutical compositions of same for use as an antimicrobial and in cancer treatment
#555Heterocyclic compounds and uses thereof
#556Methods and Compositions for Treating Thyroid-Related Medical Conditions with Reduced Folates
#557SPHINGOSINE PATHWAY MODULATING COMPOUNDS FOR THE TREATMENT OF CANCERS
#558Reduction of milk glycans and their degradation products in the neonate gut
#559Cell preparations for extemporaneous use, useful for healing and rejuvenation in vivo
#560Deuterated analogs of etifoxine, their derivatives and uses thereof
#561METHODS FOR THE TREATMENT OF ROSACEA
#562Administration of aurora kinase inhibitor and chemotherapeutic agents
#563VAP-1 INHIBITORS FOR TREATING PAIN
#564DISULFIRAM AND METAL SALT STAGGERED ORAL DOSING REGIMEN AND STAGGERED-RELEASE ORAL UNIT DOSAGE FORMS
#565Anti-CD43 antibody and use thereof for cancer treatment
#566FORMULATIONS OF MILCICLIB AND THERAPEUTIC COMBINATIONS OF THE SAME FOR USE IN THE TREATMENT OF CANCER
#567Celecoxib and amlodipine formulation and method of making the same
#568POLYNUCLEOTIDE AGENTS TARGETING ANGIOTENSINOGEN (AGT) AND METHODS OF USE THEREOF
#569COMPOSITION FOR TREATING SEIZURE DISORDERS
#570Human antibodies to influenza hemagglutinin
#571ENHANCEMENT OF IMPAIRED MOTOR AND MENTAL FUNCTIONS, USING DEXTROMETHORPHAN AND OXIDASE ENZYME INHIBITOR
#572Curcuphenol compounds for increasing MHC-I expression
#573Process for increasing the stability of a composition comprising polyunsaturated omega-3 fatty acids
#574Magnetic resonance maps for analyzing tissue
#575Magnetic resonance maps for analyzing brain tissue
#576Method of attacking target cells
#577THERAPIES FOR HEMATOLOGIC MALIGNANCIES
#578Methods for treating cancer
#579Matrix for receiving tissue samples
#580Biaryl monobactam compounds and methods of use thereof for the treatment of bacterial infections
#581Preservation of pancreatic islet grafts in the extrahepatic space
#582Enhancing the effect of CAR-engineered T cells by means of nucleic acid vaccination
#583CANCERS EXPRESSING CCR5 AND METHODS OF TREATMENT OF SAME
#584COMBINATION THERAPY USING ACAMPROSATE AND D-CYCLOSERINE
#585Combinations of acaricides and insect growth regulators for control of fleas without emesis in animals
#586Compositions and methods for viral sensitization
#587Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
#588Compositions and methods of use of phorbolesters
#589Composition comprising combination of rapamycin and an activator of AMP kinase and use thereof for treating diseases
#590Derivatives of korormicin useful as antibiotics
#591Methods for the treatment of glioblastoma multiforme
#592Compositions and methods for inhibiting arginase activity
#593Tricyclic fused pyridin-2-one derivatives and their use as BRD4 inhibitors
#594COMPOSITIONS AND METHODS FOR INDUCING NANOPARTICLE-MEDIATED MICROVASCULAR EMBOLIZATION FOR TUMORS
#595PHARMACEUTICAL COMBINATION FOR IMPROVING GLYCEMIC CONTROL AS ADD-ON THERAPY TO BASAL INSULIN
#596Compositions and methods for invasive and non-invasive procedural skincare
#597VAGINAL INSERTED ESTRADIOL PHARMACEUTICAL COMPOSITIONS AND METHODS
#5984,6-PYRIMIDINYLENE DERIVATIVES AND USES THEREOF
#599Altering microbial populations and modifying microbiota
#600Tricyclic fused derivatives of 1-(cyclo)alkyl pyrtdin-2-one useful for the treatment of cancer